AU766533B2 - New tri-substituted phenyl derivatives and analogues - Google Patents

New tri-substituted phenyl derivatives and analogues Download PDF

Info

Publication number
AU766533B2
AU766533B2 AU20351/01A AU2035101A AU766533B2 AU 766533 B2 AU766533 B2 AU 766533B2 AU 20351/01 A AU20351/01 A AU 20351/01A AU 2035101 A AU2035101 A AU 2035101A AU 766533 B2 AU766533 B2 AU 766533B2
Authority
AU
Australia
Prior art keywords
oxy
phenyl
methylsulfonyl
ethyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20351/01A
Other languages
English (en)
Other versions
AU2035101A (en
Inventor
Maria Boije
Jonas Fagerhag
Eva-Lotte Lindstedt Alstermark
Bengt Ohlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2035101A publication Critical patent/AU2035101A/en
Application granted granted Critical
Publication of AU766533B2 publication Critical patent/AU766533B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20351/01A 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues Ceased AU766533B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904421 1999-12-03
SE9904421A SE9904421D0 (sv) 1999-12-03 1999-12-03 New compounds
PCT/SE2000/002385 WO2001040172A1 (en) 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues

Publications (2)

Publication Number Publication Date
AU2035101A AU2035101A (en) 2001-06-12
AU766533B2 true AU766533B2 (en) 2003-10-16

Family

ID=20417986

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20351/01A Ceased AU766533B2 (en) 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues

Country Status (23)

Country Link
US (1) US6750252B2 (enExample)
EP (1) EP1237856B1 (enExample)
JP (1) JP2003515583A (enExample)
KR (1) KR100787072B1 (enExample)
CN (1) CN1206212C (enExample)
AR (1) AR033957A1 (enExample)
AT (1) ATE266633T1 (enExample)
AU (1) AU766533B2 (enExample)
BR (1) BR0016130A (enExample)
CA (1) CA2392039A1 (enExample)
DE (1) DE60010747T2 (enExample)
DK (1) DK1237856T3 (enExample)
ES (1) ES2219425T3 (enExample)
IL (2) IL149517A0 (enExample)
MX (1) MXPA02005223A (enExample)
MY (1) MY124727A (enExample)
NO (1) NO20022590L (enExample)
PT (1) PT1237856E (enExample)
SE (1) SE9904421D0 (enExample)
TR (1) TR200401716T4 (enExample)
TW (1) TWI224590B (enExample)
WO (1) WO2001040172A1 (enExample)
ZA (1) ZA200203798B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2364304B (en) 1997-10-27 2003-04-23 Reddy Research Foundation Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
HUP0101110A3 (en) 1997-10-27 2002-06-28 Reddys Lab Ltd Dr Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
EP1124807A1 (en) 1997-10-27 2001-08-22 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
BR9914438A (pt) 1998-10-29 2001-06-26 Reddy Research Foundation Processo aperfeiçoado para a preparação de novos agentes anti-diabéticos
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
SE0101386D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
PL369732A1 (en) * 2001-10-16 2005-05-02 Dr.Reddy's Laboratories Ltd. Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
WO2007137260A2 (en) * 2006-05-22 2007-11-29 Elan Pharmaceuticals, Inc. Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu' s reaction
KR101558005B1 (ko) 2007-03-08 2015-10-06 알비레오 에이비 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도
FR2917084B1 (fr) 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2917086B1 (fr) * 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
KR20020067537A (ko) 2002-08-22
CA2392039A1 (en) 2001-06-07
ATE266633T1 (de) 2004-05-15
NO20022590D0 (no) 2002-05-31
DE60010747T2 (de) 2005-05-19
DK1237856T3 (da) 2004-08-02
EP1237856B1 (en) 2004-05-12
US6750252B2 (en) 2004-06-15
MXPA02005223A (es) 2003-09-25
TWI224590B (en) 2004-12-01
IL149517A (en) 2007-07-04
IL149517A0 (en) 2002-11-10
CN1402703A (zh) 2003-03-12
EP1237856A1 (en) 2002-09-11
WO2001040172A1 (en) 2001-06-07
ZA200203798B (en) 2003-10-29
US20030149104A1 (en) 2003-08-07
AR033957A1 (es) 2004-01-21
AU2035101A (en) 2001-06-12
KR100787072B1 (ko) 2007-12-21
TR200401716T4 (tr) 2004-09-21
ES2219425T3 (es) 2004-12-01
SE9904421D0 (sv) 1999-12-03
JP2003515583A (ja) 2003-05-07
CN1206212C (zh) 2005-06-15
MY124727A (en) 2006-06-30
BR0016130A (pt) 2002-08-20
NO20022590L (no) 2002-07-29
DE60010747D1 (de) 2004-06-17
PT1237856E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
AU766533B2 (en) New tri-substituted phenyl derivatives and analogues
ES2209457T3 (es) Nuevos derivados del acido 3-aril-propionico, y analogos.
KR100625152B1 (ko) 신규한 3-아릴-2-히드록시프로피온산 유도체 (ｉ)
EP1084101B1 (en) New 3-aryl-2-hydroxypropionic acid derivative iii
EP1237857B1 (en) New phenalkyloxy-phenyl derivatives
MXPA00011610A (en) New 3-aryl propionic acid derivatives and analogs
HK1035711B (en) New 3-aryl-2-hydroxypropionic acid derivative (i)
HK1034957B (en) New 3-aryl propionic acid derivatives and analogs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)